The technology could help doctors find malignancies in mammograms, freeing up clinical time
ER+ breast cancers are estimated to account for 75-80 per cent of all breast cancer cases
Developers say the service presents an improved level of accuracy in breast cancer detection
The test is performed from a single saliva sample and aims to inform women of their risk profile
The company aims to reverse the rise of late-stage cervical cancer and get women up to date on their screenings
Despite promising signs of cancer screening being on the rise, gender inequalities remain
The government has pledged £10m to speed up breast cancer diagnosis and treatment
Endometrial cancer is the most commonly diagnosed gynaecologic cancer in American women
By Dr Pooja Sikka, venture partner at APEX Ventures
Over 70 per cent of women have delayed getting a Pap test, the US medtech company BD has found
